Ziprasidone vs Standard Therapy for Agitated Patients in the ED

Withdrawn before enrolling · Phase 4

Conditions studied: Psychosis, Agitation, Delirium

In brief

The primary objective is to determine if ziprasidone is superior to standard therapies in the emergency department treatment of the acutely agitated patient. The primary outcome will be the length of time taken until the patient is ready to be evaluated by the psychiatric service, or until a disposition is made.

Key facts

Study ID

NCT00786318

Run by

George Washington University

People needed

0

Starts

2008-09-01

Expected to finish

2011-07-01

Last updated by the study team

2017-09-25

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Acutely agitated
• Requires chemical sedation

You may not qualify if…

• Physician preference for a specific chemical sedative
• Known allergy to any study medications

Where it is running

• The George Washington University Medical Center, Dept of Emergency Medicine — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.